ABVX:EPA
Abivax SA
၈၃.၂၅ €
arrow_downward
-၀.၃၀%(-၀.၂၅) 1D
အောက် ၅, GMT+၂ ၁၂:၅၉:၂၈ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABVX...
Open
၈၃.၄၀ €
High
၈၃.၄၀ €
Low
၈၂.၆၅ €
Mkt. cap
၇၃၁.၃၂ ဋေ
Avg. vol.
၁.၅၆ သိန်း
Volume
၂.၀၉ သောင်း
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
Open
၈၃.၄၀ €
High
၈၃.၄၀ €
Low
၈၂.၆၅ €
Mkt. cap
၇၃၁.၃၂ ဋေ
Avg. vol.
၁.၅၆ သိန်း
Volume
၂.၀၉ သောင်း
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
NYSE logo in New York City
WFSB
·
ပြီးခဲ့သည့် ၂ နာရီ
MORNING BUSINESS REPORT: Busy week ahead on Wall Street, Social Security COLA estimate at 3.7%
Stock Titan
·
ပြီးခဲ့သည့် ၃၁ မိနစ်
After a 1-for-30 reverse split, Megan Holdings (Nasdaq: MGN) receives Nasdaq’s compliance decision.
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
Should You Invest in the First Trust NASDAQ Bank ETF (FTXO)?
Profile
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
About Abivax SA
CEOMarc de Garidel | Hartmut J. Ehrlich
Employees၉၈
Founded၂၀၁၃ ဒီ ၄
Headquarters-
Sector-
Websiteabivax.com